Search Results - "Vallabhan, R"

Experience with Extracorporeal Membranous Oxygenation Support for Cardiocirculatory Arrest Following Acute Myocardial Infarction by Shaikh, A.F, Gonzalez-Stawinski, G.V, Squiers, J.J, Chamogeorgakis, T, MacHannaford, J.C, Rafael, A.E, Vallabhan, R, Choi, J.E, Schussler, J.M, DiMaio, M, Stoler, R.C, Lima, B

Get full text

Balloon rupture during stent implantation: A novel technique of salvage with a new manual power injector by Akhtar, Salman, Johnson, Kenneth B., Dalton, Robert, Rees, Chet R., Marshall, Winston S., Vallabhan, Ravi C., Anwar, Azam

“…Pinhole leak or rupture of a stent delivery balloon is a well‐recognized technical problem encountered in vascular interventions. This event leads to…”
Get full text

The use of a new mechanically advantaged syringe for performing coronary intervention by Akhtar, S, Johnson, K B, Dalton, R, Marshall, W S, Vallabhan, R C, Anwar, A

“…To determine the utility of a new mechanically advantaged syringe in the performance of percutaneous coronary intervention. A new mechanically advantaged…”
Get more information

Effect on right ventricular volume of percutaneous Amplatzer closure of atrial septal defect in adults by Schussler, Jeffrey M., Anwar, Azam, Phillips, Sabrina D., Roberts, Brad J., Vallabhan, Ravi C., Grayburn, Paul A.

“…In adult patients with atrial septal defects (ASDs), right ventricular (RV) cavity size may return to normal after operative closure. This study demonstrated…”
Get full text

Percutaneous vascular surgery after aortic valvuloplasty: initial clinical experience by Anwar, A, Vallabhan, R, Dalton, R, Schreibfeder, M, Hill, D, Donsky, M S

“…Percutaneous balloon aortic valvuloplasty can be associated with significant vascular morbidity. Often, managing the access site prolongs the length of…”
Get more information

Percutaneous closure of multiple atrial septal defects with three Amplatzer septal occluder devices by Lander, Stuart R., Phillips, Sabrina, Vallabhan, Ravi C., Grayburn, Paul A., Anwar, Azam

“…We report on the successful closure of three atrial septal defects with three Amplatzer septal occluders in a 55‐year‐old woman. Catheter Cardiovasc Interv…”
Get full text

Validation of the i-STAT handheld activated clotting time for use with bivalirudin by Schussler, Jeffrey M, Lander, Stuart R, Wissinger, Laurie A, Anwar, Azam, Donsky, Michael S, Johnson, Kenneth B, Vallabhan, Ravi C, Wischmeyer, Jason B

“…Bivalirudin is being used more frequently as an anticoagulant in the cardiac catheterization laboratory. Newer devices, used to measure activated clotting time…”
Get full text